Baues, Christian, Schlaak, Max, von Bergwelt-Baildon, Michael and Theurich, Sebastian ORCID: 0000-0001-5706-8258 (2017). Should we be combining local tumor therapies with immunotherapies as standard? Future Oncol., 13 (18). S. 1573 - 1576. LONDON: FUTURE MEDICINE LTD. ISSN 1744-8301

Full text not available from this repository.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Baues, ChristianUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schlaak, MaxUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
von Bergwelt-Baildon, MichaelUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Theurich, SebastianUNSPECIFIEDorcid.org/0000-0001-5706-8258UNSPECIFIED
URN: urn:nbn:de:hbz:38-222499
DOI: 10.2217/fon-2017-0150
Journal or Publication Title: Future Oncol.
Volume: 13
Number: 18
Page Range: S. 1573 - 1576
Date: 2017
Publisher: FUTURE MEDICINE LTD
Place of Publication: LONDON
ISSN: 1744-8301
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
ADVANCED MELANOMA; UNTREATED MELANOMA; RADIATION-THERAPY; IPILIMUMAB; NIVOLUMAB; SURVIVAL; RADIOTHERAPY; COMBINATIONMultiple languages
OncologyMultiple languages
Refereed: Yes
URI: http://kups.ub.uni-koeln.de/id/eprint/22249

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item